What to do if papillary thyroid carcinoma metastasizes? How to treat papillary thyroid carcinoma metastasis

What should we do if papillary thyroid cancer metastasizes? No matter what kind of cancer it is, it is easy to metastasize in the middle and late stages. Once metastasis occurs, the harm will be greatly increased, which will cause serious physical and mental impact on patients. Therefore, timely treatment is very important. So what should we do if papillary thyroid cancer metastasizes?

Papillary thyroid carcinoma often metastasizes to the upper mediastinum after passing through the lymph nodes in zone VI. Sometimes the upper mediastinal lymph nodes are adhered and fused with the lymph nodes in zone VI. When the upper mediastinal metastatic lymph nodes are 3 cm in size, it is necessary to cooperate with the thoracic department to perform upper mediastinal lymph node dissection.

For those who have incomplete surgical resection or suspected incomplete resection due to low pathological differentiation, postoperative radiotherapy is necessary. For cases with distant metastasis or tendency to distant metastasis, 131I treatment is necessary.

The treatment of papillary thyroid carcinoma is mainly based on surgery, with postoperative adjuvant radionuclide therapy and radiotherapy if necessary. Regardless of the pathological type, surgical resection should be performed as much as possible as long as there is an indication for surgery. For those with residual tumors after surgery and a small tumor burden, postoperative radiotherapy has a certain value. The specific implementation should be based on the surgical resection situation, pathological type, lesion range, age and other factors: For well-differentiated papillary carcinoma or follicular carcinoma, even if there is a local recurrence after surgery, surgery can be performed again, and radical cure or long-term palliative effect can still be achieved. If there is residual tumor or extensive lymph node metastasis after surgery, postoperative radiotherapy should be given in time to reduce the local recurrence rate as much as possible and improve the prognosis.